Recordati SpA (OTCPK:RCDTF)
$ 52.25 0 (0%) Market Cap: 11.25 Bil Enterprise Value: 13.17 Bil PE Ratio: 27.82 PB Ratio: 5.89 GF Score: 92/100
Back to the Transcripts List

Q3 2024 Recordati Industria Chimica e Farmaceutica SpA Earnings Call Transcript

Nov 8, 2024 / 03:00 PM GMT
Release Date Price: $52.25

Key Points

Positve
  • Recordati SpA (RICFY) reported a 12% increase in net revenue for the first nine months of 2024, reaching 1.743 billion euros.
  • The company achieved an EBITDA margin of 38.2%, reflecting strong profitability.
  • Recordati SpA (RICFY) confirmed its full-year 2024 financial targets, which were upgraded in July, indicating confidence in continued business momentum.
  • The acquisition of global rights to NJO from Sanofi is expected to contribute positively to EBITDA from 2025 onwards.
  • Recordati SpA (RICFY) reported a robust free cash flow of 434.3 million euros, up 11% from the previous year.
Negative
  • The company faced adverse effects in Turkey due to recent devaluation and timing of price increases, impacting growth.
  • There is volatility in quarterly EBITDA margins due to seasonal factors and hyperinflation accounting in Turkey.
  • The metabolic franchise experienced mild erosion in the US due to generic entries affecting Carbaglu.
  • Recordati SpA (RICFY) anticipates higher financing expenses in 2025 due to the NJO acquisition.
  • The company expects minimal financial contribution from NJO in 2024, pending regulatory approvals.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RECI.MI - Recordati Industria Chimica e Farmaceutica SpA
Q3 2024 Recordati Industria Chimica e Farmaceutica SpA Earnings Call
Nov 08, 2024 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon. This is the chorus call conference operator. Welcome. And thank you for joining the Recordati results for the first nine months of 2024 conference call. As a reminder, all participants are in listen-only mode. After the presentation, there will be an opportunity to ask questions. Should anyone need assistance during the conference call? They may signal an operator by pressing star and zero on their telephone. At this time, I would like to turn the conference over to MS Eugenia Leeds, Vice President of Investor Relations of Recordati. Please go ahead madam.

--------------------------------------------------------------------------------
Unidentified_2 [2]
Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.